(%)
As on LastTradeTime IST
| Open | Volume | ||
|---|---|---|---|
| High | Value | ||
| Low | VWAP | ||
| Avg Price | MarketCap | ||
| LTP | 52 week High | ||
| Prev Close | 52 week Low | ||
| Price change | % change |
| Year Ending | 2021-03-31 | Current Reserves | 7507870000 |
|---|---|---|---|
| Current Equity | 245054344 | EPS | 28.6941 |
| Book Value | 63.2751 | Beta | 0 |
| PE | 18.157 | PB | 8.2338 |
| Dividend Yield | 0 | Market Cap | 63806024819 |
| CompanyName | Glenmark Life Sciences Ltd. | Short Name | Glenmark Life Scienc |
|---|---|---|---|
| Sector | Pharmaceuticals and health care | Industry | Pharmaceuticals |
| Business Group | Not Applicable | CINNo | L74900PN2011PLC139963 |
| Incorporation Date | 2011-06-23 | First Public Issue Date | 2021-07-27 |
| Incorporation Year | 2011 | First Public Issue Year | 2021 |
| Ticker | GlenmarkLife | ISIN Code | INE03Q201024 | |
|---|---|---|---|---|
| Description | Glenmark Life Sciences Ltd. | Security Type | Equity Share | |
| Issue Price | 718 | Date Of Issue | 2021-08-03 | |
| Face Value | 2 | Date Of Expiry | ||
| Market Lot | 1 | |||
- Advances - 0
- Declines - 0
- Unchanged - 0
| SYMBOL | Industry | PREV.CLOSE | LTP | CHNG | MarketCap | Weight(%) | Contribution |
|---|
